ANA SAAVEDRA MENDEZ: Open Payments
NPI 1083356091 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$689 in 37 payments from 13 companies in 2025. Trend: 2023 $272 · 2024 $669 · 2025 $689
Food & beverage: $689
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $148 |
| Lilly USA, LLC | 8 | $125 |
| Novo Nordisk Inc | 4 | $90 |
| Amgen Inc. | 4 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
| Hologic Sales and Service, LLC | 1 | $42 |
| Dexcom, Inc. | 2 | $37 |
| Exact Sciences Corporation | 2 | $32 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| PFIZER INC. | 1 | $19 |
Products named: MOUNJARO, AIRSUPRA, JARDIANCE, KRYSTEXXA, FARXIGA, Rybelsus, APTIMA, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
